Trastuzumab Plus Ramucirumab and Paclitaxel for Previously Treated HER2-Positive Advanced Gastric or GEJ Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric or Gastroesophageal Junction Cancer
J. Clin. Oncol 2023 Jun 26;[EPub Ahead of Print], CG Kim, M Jung, HS Kim, CK Lee, HC Jeung, DH Koo, WK Bae, DY Zang, BJ Kim, H Kim, UJ Yun, J Che, S Park, TS Kim, WS Kwon, J Park, SW Cho, CM Nam, HC Chung, SY RhaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.